Treace Medical Concepts, Inc.TMCINASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +10.62% | +10.44% | +2.86% | +6.60% | +11.37% |
| Gross Profit Growth | +10.29% | +9.33% | +2.23% | +5.82% | +9.89% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +1.08% | +1.04% | +1.41% | +1.49% | +2.07% |
| Weighted Average Shares Diluted Growth | +1.08% | +1.04% | +1.41% | +1.49% | +2.07% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | -890.79% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -3.28% | +7.20% | +3.41% | +18.68% | +36.32% |
| Inventory Growth | +48.78% | +34.23% | +5.80% | +2.71% | -5.01% |
| Asset Growth | -11.41% | -13.82% | -15.19% | -8.69% | -7.67% |
| Book Value per Share Growth | -24.72% | -19.00% | -17.81% | -14.23% | -16.71% |
| Debt Growth | -0.52% | -0.92% | -1.07% | +0.35% | +0.36% |
| R&D Expense Growth | +14.09% | +25.48% | +5.76% | +6.61% | -5.70% |
| SG&A Expenses Growth | +0.16% | -5.44% | -5.08% | -5.15% | +7.34% |